Palbociclib (Ibrance) - Oncology Nurse Advisor

Palbociclib (Ibrance)

Slideshow

  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.
  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.
  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.
  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.
  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.
  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.
  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.
  • Slide

  • Slide

  • Slide

This slideshow reviews palbociclib (Ibrance), indicated for Hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced or metastatic breast cancer .

Table of Contents

Slide 4: Dosage and Administration
Slide 14: Cautions, Effects, and Interactions
Slide 19: What to Tell Your Patient
Slide 24: Reference